ID   WAe001-A-14
AC   CVCL_VE33
SY   GDE-C11; GIBHe007-A-14
DR   hPSCreg; WAe001-A-14
DR   Wikidata; Q54993541
RX   PubMed=29310060;
CC   From: Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences; Guangzhou; China.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; 321; AGL (Note=1 of 2 alleles).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=29310060
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 8,11
ST   D16S539: 9,13
ST   D18S51: 17,18
ST   D19S433: 13,15
ST   D21S11: 28,32.2
ST   D2S1338: 18,19
ST   D3S1358: 15
ST   D5S818: 9,11
ST   D7S820: 8,12
ST   D8S1179: 12,13
ST   FGA: 20,24
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 15,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 30-01-24; Version: 7
//
RX   PubMed=29310060; DOI=10.1016/j.scr.2017.12.009;
RA   Xu G.-S., Guo D.-S., Wu F.-M., Abbas N., Lai K.-Y., Yuan F., You K.,
RA   Liu Y.-L., Zhuang Y.-Q., Wu Y.-H., Xu Y.-Y., Chen Y., Yang F.,
RA   Pan T.-C., Li Y.-X.;
RT   "Generation of a GDE heterozygous mutation human embryonic stem cell
RT   line WAe001-A-14 by CRISPR/Cas9 editing.";
RL   Stem Cell Res. 27:38-41(2018).
//